There has rarely been a more exciting time to be involved in Life Sciences. This is a time when genetic material can be edited with precision; when the power of the immune system is being harnessed to cure disease; and when bioinformatics and big data open the door for treatments that are truly bespoke for each person. We are proud to offer IP support to innovator companies across this rapidly evolving field.

Our large and vastly experienced team leads the way in life sciences patents. From therapeutics to medical devices, genetic engineering and diagnostics, we cover every aspect. We have been working to protect these inventions since the earliest days of the biotechnology revolution, and we have been shaping IP law in this area since the very beginning. We combine our years of experience with creative, fresh thinking, to design IP strategies that will work in a changing world.

Mewburn Ellis is consistently regarded as a leading choice for IP protection among the world’s top biopharmaceutical companies.  We have deep experience of working to protect high-profile biologics. IP specialists in the team were the European representatives for half of the top ten selling biologic drugs in 2017. The combined annual sales for these drugs amounted to around $50 billion.  Our experience in supporting biologic therapies from conception through to market is complemented by the expertise of pharmaceuticals IP specialists within our chemistry group.

Life Sciences innovation focus

telescope

Biologics & Cell Therapies

Learn More
telescope

Nucleic Acids & Molecular Biology

Learn More
telescope

Diagnostics & Precision Medicine

Learn More
telescope

Industrial & Agricultural Biotech

Learn More

Life Sciences patent experts

We have long been at the forefront of developing EPO practice in the life sciences field.  For instance, we’ve helped to secure recognition of the patentability of therapeutic treatments based on new diagnostic regimens, new technical effects and new patient subgroups. These influential decisions have helped our clients to protect their investment throughout the drug life cycle.

Our Life Sciences patent team is distinguished by its large number of highly experienced attorneys. Some firms can offer one or two leading figures, we have many. We have an excellent reputation for opposition and appeal work before the EPO and we have many partners who are highly active in this area. This enables us to give each case the attention it requires, and contributes to our enviable success rate.

We also have a strong track record in nurturing inventions arising from universities and research organisations. We have provided the IP foundation on which numerous biotechnology start-up & spin-out companies have been built, and we are proud to have supported many companies through to successful IPO, acquisition or expansion.

Of course, a strong IP strategy in life sciences is about much more than just patents.  As one of the largest IP specialist firms in Europe, Mewburn Ellis can offer a wealth of relevant expertise, from trade mark protection to Plant Variety Rights (PVRs).  Our legal services team is distinguished by a strong technical background in life science and considerable experience in dealing with regulatory issues, clinical trial practice, and IP exploitation in the this sector.  We also have unparalleled expertise in Supplementary Protection Certificates (SPCs), with over twenty years of continuous experience since obtaining the first UK SPC in 1993. 


MEET OUR LIFE SCIENCES PATENT TEAM

What our clients say about us

“The consistency provided by the team at Mewburn Ellis since 2000 has been critical for the development of our successful IP strategy."

CHARLES HARRINGTON

WisTa Laboratories Ltd

"Simon Kiddle is cleantech guru, with the ability to craft spotless patents and defend the least promising EPO cases with remarkable success."

IAM PATENT 1000

Legal Directories

"Seán Walton is the guy you pick if you want quality."

IAM PATENT 1000

Legal Directory

"Simon Kremer's 'silky' life sciences prosecution skills that allow him to work wonders on EPO judges."

IAM PATENT 1000

Legal Directory

Law & Practice Library

EUROPEAN PATENTS - THE BASICS

Veriviva strarbis vita, senaticumderunu statior terobse nenatuastuus essis rena, quam, perfirte, sesessis, nos, quo vicavo

Learn More

JOINT APPLICATIONS ORCO-OWNERS OF IP

Veriviva strarbis vita, senaticum derunu statior terobse nenatuastuus essis rena, quam, perfirte, sesessis, nos, quo vicavo

Learn More

MARKING OF PATENTED PRODUCTS IN THE UK

Veriviva strarbis vita, senaticum derunu statior terobse nenatuastuus essis rena, quam, perfirte, sesessis, nos, quo vicavo

Learn More

Latest News & Insights